NCT02171650View on ClinicalTrials.gov

BIBW 2992 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 1, 2004

Primary Completion Date

May 1, 2006

Conditions
Neoplasms
Interventions
DRUG

BIBW 2992

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY